Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.

The potential for a pharmacokinetic interaction between epirubicin and the second-generation multidrug resistance modulating agent D-verapamil (DVPM) has been investigated in six patients with advanced colorectal cancer. Our results indicate that a significant interaction takes place. Enhanced distr...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheithauer, W., Schenk, T., Czejka, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968306/
https://www.ncbi.nlm.nih.gov/pubmed/8318424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968306/
https://www.ncbi.nlm.nih.gov/pubmed/8318424

Ejemplares similares